Literature DB >> 3098992

Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence. Correlation with plasma testosterone levels.

R T Kirkland, B S Keenan, J L Probstfield, W Patsch, T L Lin, G W Clayton, W Insull.   

Abstract

A three-phase study tested the hypothesis that the decrease in the high-density lipoprotein cholesterol (HDL-C) level observed in boys at puberty is related to an increase in the plasma testosterone concentration. In phase I, 57 boys aged 10 to 17 years were categorized into four pubertal stages based on clinical parameters and plasma testosterone levels. These four groups showed increasing plasma testosterone values and decreasing HDL-C levels. In phase II, 14 boys with delayed adolescence were treated with testosterone enanthate (100, 200, and 200 mg/mo, respectively, for three months). Plasma testosterone levels during therapy were in the adult male range. Levels of HDL-C decreased by a mean of 7.4 mg/dL (0.20 mmol/L) and 13.7 mg/dL (0.35 mmol/L), respectively, after the first two doses. In phase III, 13 boys with delayed adolescence demonstrated increasing plasma testosterone levels and decreasing HDL-C levels (-12.0 mg/dL [-0.30 mmol/L]) during spontaneous puberty. Levels of HDL-C and apolipoprotein A-1 were correlated during induced and spontaneous puberty. Testosterone should be considered a significant determinant (not necessarily directly causal) of plasma HDL-C levels during pubertal development.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3098992

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  19 in total

1.  Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice.

Authors:  C Alicia Traughber; Emmanuel Opoku; Gregory Brubaker; Jennifer Major; Hanxu Lu; Shuhui Wang Lorkowski; Chase Neumann; Aimalie Hardaway; Yoon-Mi Chung; Kailash Gulshan; Nima Sharifi; J Mark Brown; Jonathan D Smith
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

2.  The smoker's paradox and the real risk of smoking.

Authors:  Friedebert Kunz; Christoph Pechlaner; Helmut Hörtnagl; Rudolf Pfister
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  Anabolic-androgenic steroid effects on endocrinology and lipid metabolism in athletes.

Authors:  M Alén; P Rahkila
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

4.  Passive and Active Tobacco Exposure and Children's Lipid Profiles.

Authors:  Joseph Zakhar; Stephen M Amrock; Michael Weitzman
Journal:  Nicotine Tob Res       Date:  2015-07-17       Impact factor: 4.244

Review 5.  Testosterone therapy in men: clinical and pharmacological perspectives.

Authors:  A Gambineri; R Pasquali
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

6.  All-cause mortality and mortality of myocardial infarction for 989 legally castrated men.

Authors:  Finn Edler von Eyben; Christian Graugaard; Michael Vaeth
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

7.  Testosterone and insulin resistance in the metabolic syndrome and T2DM in men.

Authors:  Preethi M Rao; Daniel M Kelly; T Hugh Jones
Journal:  Nat Rev Endocrinol       Date:  2013-06-25       Impact factor: 43.330

Review 8.  Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.

Authors:  C Cattabiani; S Basaria; G P Ceda; M Luci; A Vignali; F Lauretani; G Valenti; R Volpi; M Maggio
Journal:  J Endocrinol Invest       Date:  2011-11-08       Impact factor: 4.256

9.  Monocyte proinflammatory cytokine release is higher and glucocorticoid sensitivity is lower in middle aged men than in women independent of cardiovascular risk factors.

Authors:  P H Wirtz; R von Känel; N Rohleder; J E Fischer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

10.  Higher testosterone levels are associated with increased high-density lipoprotein cholesterol in men with cardiovascular disease: results from the Massachusetts Male Aging Study.

Authors:  Stephanie T Page; Beth A Mohr; Carol L Link; Amy B O'Donnell; William J Bremner; John B McKinlay
Journal:  Asian J Androl       Date:  2007-12-20       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.